On the contrary, the results of the NAFLD-HCC model indicated that under WD, Plin5−/− mice have increased expression of Cpt1, while no changes were observed in the rest of the markers analyzed (Fig. 3E). Here, PLIN5 is linked to metabolic dysfunction-associated steatotic liver disease.